The generic drug market in Japan: Will it finally take off?

Toshiaki Iizuka, Kensuke Kubo

研究成果: Article査読

12 被引用数 (Scopus)

抄録

Historically, brand-name pharmaceuticals have enjoyed long periods of market exclusivity in Japan, given the limited use of generics after patent expiration. To improve the efficiency of the health-care system, however, the government has recently implemented various policies aimed at increasing generic substitution. Although this has created expectations that the Japanese generic drug market may finally take off, to date, generic usage has increased only modestly. After reviewing the incentives of key market participants to choose generics, we argue that previous government policies did not provide proper incentives for pharmacies to boost generic substitution. We offer some recommendations that may help to increase generic usage.

本文言語English
ページ(範囲)369-389
ページ数21
ジャーナルHealth Economics, Policy and Law
6
3
DOI
出版ステータスPublished - 2011 7月 1
外部発表はい

ASJC Scopus subject areas

  • 健康政策

フィンガープリント

「The generic drug market in Japan: Will it finally take off?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル